Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Research
Massachusetts most impacted by NIH research cuts: Grant Witness
Massachusetts has lost over $1.3 billion in terminated research grants from the NIH, making it one of the most impacted states by the federal cuts.
Gabrielle Masson
Sep 18, 2025 9:38am
FDA warns against unreviewed blood pressure tech, baby monitors
Sep 17, 2025 12:00pm
FDA updates recall for Boston Scientific implanted defib leads
Sep 15, 2025 11:55am
aTyr flunks phase 3 lung disease trial, deflating stock
Sep 15, 2025 9:56am
Fierce Pharma
Under Trump, FDA seeks to abandon expert reviews of new drugs
Sep 12, 2025 9:50am
Arrowhead sues Ionis over patent dispute for Tryngolza rival
Sep 11, 2025 11:33am
